Japanese pharmaceutical giant Mitsubishi Tanabe Pharma Corp. announced that a COVID-19 vaccine derived from a type of tobacco ...

A Sept. 17 Instagram post (direct link, archive link) shows a video about a Canadian pharmaceutical company using plants to help develop and produce vaccines. “MRNA vegetables," reads part of the post ...

Biotechnology company Medicago (TSX:MDG) could soon demonstrate whether its technology can rapidly develop and manufacture vaccines to respond to potential pandemic ...

A Canadian drugmaker said its plant-based COVID-19 vaccine showed strong protection against the virus and will soon seek authorization at home and elsewhere. Medicago announced Tuesday that its ...

A plant-based vaccine producer will lay off 60 people at its Research Triangle Park office, a new filing shows. On Wednesday, the Canadian company Medicago sent a WARN notice to the N.C. Department of ...

TORONTO, Jan 11 (Reuters) - Medicago Inc will participate in an early-stage clinical trial of a vaccine designed for use in the event of an avian pandemic flu outbreak, the Canadian biotechnology ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Months after laying off ...

Preliminary safety and immunogenicity results are expected in October 2020 Dynavax is providing CpG 1018, the adjuvant contained in its U.S. FDA-approved adult hepatitis B vaccine, to enhance the ...

IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc.